Identifying candidate genes for Parkinson's disease by integrative genomics method;Identifikacija gena kandidata za Parkinsonovu bolest metodom integrativne genomike

Biochemia Medica

Volumn 21, Issue 2, 2011, Pages 174-181

  Karic, Amela ^a   Terzic, Rifet ^a   Karic, Alen ^b   Peterlin, Borut ^c  

^a UNIVERSITY OF TUZLA   (Bosnia and Herzegovina)

^b Medical Centre of Tuzla   (Bosnia and Herzegovina)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Biomedical discovery support system (BITOLA); Candidate genes; Parkinson's disease

Indexed keywords

GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; N ETHYLMALEIMIDE SENSITIVE FACTOR; PARKIN; PROTEIN CDC42; TAU PROTEIN; UBIQUITIN THIOLESTERASE;

ALGORITHM; ARTICLE; BIBLIOGRAPHIC DATABASE; BIOMEDICAL DISCOVERY SUPPORT SYSTEM; CDC 42 GENE; CHROMOSOME 11P; CHROMOSOME 17Q; CHROMOSOME 18P; CHROMOSOME 2P; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 9Q; DECISION SUPPORT SYSTEM; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOMICS; GFPT 1 GENE; HUMAN; INTEGRATIVE GENOMICS; MAPT GENE; NSF GENE; PARK 2 GENE; PARKINSON DISEASE; TRANSCRIPTOMICS; UCHL 1 GENE;

EID: 79960120136     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/bm.2011.027     Document Type: Article

References (39)

1. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, et al. Molecular markers of early Parkinsn's disease based on gene expression in blood. Proc Natl Acad Sci USA 2007;104:955-60.
2. Grimes DA, Han F, Panniset M, Racacho L, Xiao F, Zou R, et al. Translated Mutation in the Nurr1 Gene as a Cause for Parkinson's Disease. Mov Disord 2006;21:906-9.
3. Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioa-nnidis JP, Kruger R, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson's disease. JAMA 2006;296:661-70.
4. Feany MB. New Genetic Insights into Parkinson's disease. N Engl J Med 2004;351:1937-40.
5. Pankratz N, Nichols WC, Uniacke SK. Genome-wide linkage analysis and evidence of gene-by-gene interaction in a sample of 362 multiplex Parkinson's disease families. Hum Mol Genet 2003;12:2599-608.
6. Scott WK, Nance MA, Watts RL. Complete genomic screen in Parkinson's disease/evidence for multiple genes. JAMA 2002;286:2239-44.
7. Martinez M, Brice A, Vaughan JR. Genome-wide scan for Parkinson's disease/the Gene PD Study. Neurology 2004;41:900-7.
8. Elbaz A, Nelson ML, Payami, oannidis JP, Fiske BK, Anne-si G, et al. Lack of Replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's Disease: a large-scale international study. Lancet Neurol 2006;5:917-23.
9. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, et al. Age at onset in two common neurodegenera-tive diseases is genetically controlled. Am J Hum Genet 2002;70:985-93.
10. Schiesling C, Kieper N, Seidel K, Kruger R. Review: Familial Parkinson's disease - genetics, clinical phenotype andne-uropathology in relation to the common sporadic form of the disease. Neuropathol Appl Neurobiol 2008;34:255-71.
11. Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirs-ch J, Rechavi G, Youdim MB. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars com-pacta reveals impairment of ubiquitin-proteasome subu-nits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann N Y Acad Sci 2005;1053:356-75.
12. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003;53:26.
13. Hulley P, Schachner M, Lubbert H. L1 Neural cell Adhesion Molecule /s a Survival Factor for Fetal Dopaminergic Neurons. J Neurosci Res 1998;53:129-34.
14. Journal of Nuroscience research 1998;53:129-34.
15. Mandel SA, Fishman T, Youdim MB. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD. Parkinsonisms Relat Disord 2007;13:242-7.
16. Jorgensen OS. Neural Cell Adhesion Molecule (NCAM) as a quantitative marker in synaptic remodeling. Neurochem Res 1995;20:533-47.
17. Barcia C, Barreiro AF, Poza M, Trinidad M. Parkinson's disease and /mmflamatory Changes. Neurotox Res 2003;5:411-8.
18. Biomedical Discovery Support System (BITOLA). Available at: http://ibmi.mfuni-lj.si/bitola/accessed from 2005 to 2010.
19. Hristovski D, Peterlin B, Dzeroski S, Stare J. Literature Based Discovery Support System and its Application to Disease Gene identification. Proc AMIA Symp 2001;928.
20. Hristovski D, Stare J, Peterlin B, Dzeroski S. Supporting Discovery in Medicine by Association Rule Minining in Medline and UMLS. Stud Health Technol /nform 2001;84:1344-8.
21. Hristovski D, Peterlin B, Mitchell JA, Humphrey SM. Improving Literature Based Discovery Support by Genetic Knoweledge Integration. Stud Health Technol Inform 2003;95:68-73.
22. U.S. National Library of Medicine-MEDL/NE. Available at: http://nlm.nih.gov/databases/databases_MEDL/NE/. Accessed from 2005 to 2010.
23. U.S.National Library of Medicine-MEDL/NE. Available at: http://nlm.nih.gov/sites/entrez/databases/. Accessed from 2005 to 2010.
24. GeneCards. Available at: http://genecards.org/. Accessed from 2005 to 2008.
25. Online Mendelian /nheritance in Man (OM/M). Available at: http://nlm.nih.gov/omim/. Accessed from 2005 to 2008.
26. Medical Subject Headings-MeSH. Available at: http://nlm. nih.gov/mesh/. Accessed from 2005 to 2008.
27. Hauser MA, Li YJ, Xu, H, Noureddine MA, Shao YS, Gu-llans SR, et al. Expression Profiling of Substantia Nigra in Parkinson's Disease, Progressive Supranuclear Palsy and FrontoTemporal dementia with Parkinsonism. Arch Neurol 2005;62:917-21.
28. Chung CY, Seo H, Sonntag KC, Brooks A, Lin L, sacson O. Cell type-specific gene expression of midbrain dopaminer-gic neurons reveals moleculs involved in their vulnerability and protection. Hum Mol Genet 2005;14:1709-25.
29. Anatharam V, Lehrmann E, Kanthasamy A, Yang Y, Baner-jee P, Becker KG, et al. Microarray Analysis of Oxidative Stress Regulated Genes in Mesencephalic Dopaminergic Neu-ronal Cells: Relevance to Oxidative Damage in Parkinson's Disease. Neurochem Int 2007;50:834-47.
30. Scherzer CR, Euklund AC, Morse LJ, Liao Z, locascio JJ, Fe-fer D, et al. Molecular Markers of early Parkinson's Disease based on gene expression in blood. Proc Natl Acad Sci USA 2007;104:955-60.
31. Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG. Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis 2007;26:606-14.
32. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB, et al. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 2006;7:1-11.
33. Zhao C, Slevin JT, Whiteheart SW. Cellular function of NSF: Not just SNAPs and SNAREs. FEBS Lett 2007;581:2140-9.
34. Matsushita K, Morrell CN, Mason RJ, Yamakuchi M, Khan-day FA, Irani K, Lowenstein CJ. Hydrogen peroxide regulation of endothelial exocytosis by inhibition of N-ethylmalei-mide sensitive factor. J Cell Biol 2005;170:73-9.
35. Morrell CN, Matsushita K, Lowenstein CJ. A novel inhibitor of N-ethylmaleimide-sensitive factor decreases leukocyte trafficking and peritonitis. J Pharmacol Exp Ther 2005;314:155-61.
36. Pittman Am, Fung HC, de Silva R. Untatling the tau gene association with neurodegenerative disorders. Human Molecular Genetics 2006;15:188-95.
37. Oppenheim RW. Cell death during development of the nervous system. Annu Rew Neurosci 1991;14:453-501.
38. Bazenet CE, Mota M, Rubin LL. The small GTP-binding protein Cdc42 is required for nerve growth factor withdrawal-induced neuronal death. Proc Natl Acad Sci USA 1998;95:3984-89.
39. Daniell PK Ng, Walker WH, Chia KS, Choo S, Krolewski AS. Scrutiny of the Glutamine-Fructose-6-Phosphate Transa-minase 1 (GFPT1) Locus Reveals Conserved Nephropathy. Diabetes 2004;53:865-9.